company

FORSKNINGSFONDET FOR ASTMA OG ALLERGI

0166 OSLO

Return on Equity
−11,42 %
Current Ratio
51,7
Debt-to-Equity Ratio
0
Key figures (NOK)2022
Revenue395 000
Net Income−2 050 000
Total Assets18 301 000
Total Equity17 947 000
Income (NOK)2022
Revenue395 000
Expenditure113 000
Operating Profit282 000
Financial Income7 000
Financial Costs2 340 000
Financial Balance−2 333 000
Earnings Before Tax−2 050 000
Tax0
Net Income−2 050 000
Balance (NOK)2022
Total Fixed Assets0
Total Current Assets18 301 000
Total Assets18 301 000
Total Retained Equity15 130 000
Total Equity17 947 000
Total Long-Term Debt0
Total Current Debt354 000
Total Equity and Debt18 301 000
Cash flow (NOK)2022
Sales Income395 000
Other Income0
Revenue395 000
Cost of Goods Sold0
Salary Costs0
Depreciation0
Impairment0
Expenditure113 000
Operating Profit282 000
Financial Income7 000
Financial Costs2 340 000
Financial Balance−2 333 000
Dividends0
Net Income−2 050 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets0
Total Fixed Assets0
Stock0
Total Investments17 493 000
Cash, Bank694 000
Total Current Assets18 301 000
Total Assets18 301 000
Total Equity17 947 000
Short-Term Group Debt0
Total Long-Term Debt0
Creditors54 000
Unpaid Taxes0
Dividends0
Other Current Debt300 000
Total Current Debt354 000
Total Equity and Debt18 301 000
Financial indicators2022
Return on Equity−11,42 %
Debt-to-Equity Ratio0
Operating Profit Margin71,39 %
Current Ratio51,7
Quick Ratio51,7
Equity Ratio0,98
Gross Profit Margin100 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English